FDA releases underwhelming "least burdensome" guidance
This article was originally published in Clinica
Executive Summary
The US FDA's long-awaited guidance on how it plans to interpret the "least burdensome" provision of the FDA Modernization Act was released last week to a less than enthusiastic reception from the medical device industry.